腹腔镜下袖状胃切除术治疗高体重指数2型糖尿病的效果分析 |
| |
引用本文: | 朱信强,黄海龙,蒋学通,孙喜太.腹腔镜下袖状胃切除术治疗高体重指数2型糖尿病的效果分析[J].中华普外科手术学杂志(电子版),2020,14(2):132-135. |
| |
作者姓名: | 朱信强 黄海龙 蒋学通 孙喜太 |
| |
作者单位: | 1. 223800 江苏宿迁,徐州医科大学附属宿迁医院普外科
2. 210008 南京,南京大学医学院附属鼓楼医院普外科 |
| |
基金项目: | 宿迁市指导性科技计划项目(Z2018065)。 |
| |
摘 要: | 目的探讨腹腔镜袖状胃切除术(LSG)治疗高体重指数2型糖尿病(T2DM)患者的可行性及疗效的稳定性。
方法回顾性分析2010年至2016年间两个医院24例实施LSG的T2DM患者的临床资料,所有数据建立完整的excel表格,采用SPSS 17.0分析。术前术后体重和糖化血红蛋白(HBALc)水平以(
±s)表示,采用t检验;分类数据以频率和百分比表示,采用卡方检验。P<0.05认为差异有统计学意义。
结果24例患者平均基线体重为(117.2±30.2) kg,在术后3个月、6个月、12个月和24个月时显著下降至(100.3±22.1) kg、(91.6±22.4) kg、(81.3±16.5) kg和(80.3±14.3) kg, P<0.001。术前平均基线HbA1c为(8.5±2.2)%,分别在3个月、6个月、12个月和24个月显著降低至(6.4±1.6)%,(5.8±1.1)%, (5.7±0.7)%和(5.3±0.6)% P<0.001。19例接受袖状胃切除术的T2DM患者停止使用胰岛素和口服降糖药,根据血糖控制标准,24例患者24个月缓解率达79.2%。除1例继续使用2种降压药外,其余高血压患者(17例)停止降压药治疗。
结论LSG治疗高体重T2DM患者,方法简单,手术安全,治疗效果确切,值得在临床中普遍推广应用。
|
关 键 词: | 糖尿病 袖状胃切除术 腹腔镜 胃切除术 高体重指数 |
收稿时间: | 2019-01-19 |
Clinical Analysis of laparoscopic sleeve gastrectomy in treating patients with type 2 diabetes and high BMI |
| |
Authors: | Zhu Xinqiang Huang Hailong Jiang Xuetong Sun Xitai |
| |
Institution: | 1. Department of General Surgery, Suqian Hospital, Xuzhou Medical University, Jiangsu 223800, China
2. Department of General Surgery, Nanjing Drum Tower Hospital, Nanjing University Medical School, Jiangsu 210008, China |
| |
Abstract: | Objective To investigate the feasibility and efficacy of laparoscopic sleeve gastrectomy(LSG) in the treatment of patients with type 2 diabetes(T2 DM) and high body mass index(BMI). Methods The clinical data of 24 patients with T2DM and high BMI who underwent LSG were analyzed retrospectively from 2010 to 2016. Statistical analysis were performed by using SPSS 17.0 software package. Measurement data such as preoperative/postoperative body weight and HbAlc levels were expressed as (x±s) and examined by using independent t-test. Count data were expressed as frequency and percentage, and were compared by using χ^2 test. A P value of <0.05 was considered as statistically significant difference. Results The average baseline weight of 24 patients was(117.2±30.2) kg, which decreased significantly to(100.3±22.1) kg,(91.6±22.4) kg,(81.3 ± 16.5) kg and(80.3 ± 14.3) kg at 3 months, 6 months, 12 months and 24 months after surgery respectively(P<0.001). The preoperative average baseline HbA1 c was(8.5±2.2)%, which was significantly decreased to(6.4±1.6)%,(5.8±1.1)%,(5.7± 0.7)% and(5.3±0.6)% at 3 months, 6 months, 12 months, and 24 months, respectively(P<0.001). 19 patients with type 2 diabetes who underwent sleeve gastrectomy discontinued insulin and oral hypoglycemic agents. According to the level of blood glucose control, remission rate of 24 patients was 79.2% 24 months after surgery. Except one case, other 17 patients with hypertensive stopped antihypertensive treatment after surgery. Conclusion LSG is a safe,feasible and effective for the treatment of patients with T2 DM and high BMI. It is worthy of widespread clinical application. |
| |
Keywords: | Diabetes mellitus Sleeve gastrectomy Laparoscopes Gastrectomy High body mass index |
本文献已被 CNKI 维普 等数据库收录! |
| 点击此处可从《中华普外科手术学杂志(电子版)》浏览原始摘要信息 |
| 点击此处可从《中华普外科手术学杂志(电子版)》下载免费的PDF全文 |
|